ArticleFrontiers in oncology2026

Short-term efficacy and safety of recombinant human adenovirus type 5 combined with PD-1 immune checkpoint inhibitors and SOX regimen in neoadjuvant therapy of locally advanced gastric cancer: a retrospective study.

Xue Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.